Mobocertinib succinate capsule dosage

Mobocertinib (Mobocertinib) is a kinase inhibitor. Mobocertinib capsules for oral administration contain the equivalent of 48.06mgMobocertinibsuccinate ester of 40mgmobocertinib. The name of the original drug of mobosetinib currently on the market in China is mobosetinib succinate capsules, and the brand name is EXKIVITY. It is not yet included in medical insurance. The common strength is 40 mg. It is an oral drug used to treat advanced or metastatic non-small cell lung cancer (NSCLC) with positive EGFR gene mutations. Adult patients are usually recommended to take it orally once a day at a dose of 160 mg.